All about health

Brii Biosciences Limited ("Brii Bio," or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health across diseases with high unmet medical needs provided a corporate update today and reported its...

Applications are now being accepted for ApolloMD's 2025 Emergency Medicine Scholarship for Residents. Experience the full interactive Multichannel News Release here:...

dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced its financial and operating results for the fourth quarter and full year ended...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene elimination, gene insertion, and gene excision programs, today announced...

OTC Markets Group Inc. , operator of regulated markets for trading 12,000 U.S. and international securities, today announced NIGHTINGALE HEALTH OYJ , a company focused on preventative healthcare, has qualified to trade on the OTCQX® Best Market....

Conavi Medical Corp. ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to provide...

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that it has rescheduled its previously announced fourth quarter and full year...

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, celebrated excellence and innovation in life sciences during the Prix Galien India Forum and second annual Modi Prix Galien Awards Gala last...

Getting quality medical care just got easier in Gilbert! MY DR NOW is opening a brand-new primary care clinic designed to fit into your schedule?open seven days a week with extended hours....

Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT)...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some...

The European Institute of Innovation & Technology (EIT) has announced the final registration call for the 2025 EIT Jumpstarter. The EIT is an EU body, which aims to train and convert innovative ideas into budding businesses. This flagship EU...

From March 11 to 14, Aquatech Amsterdam 2025, a premier global event in water treatment, took place at the RAI Amsterdam Convention Centre. Recognized as an industry-leading exhibition covering all aspects of water treatment, this year's event drew...

With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

As International Women's Month highlights the importance of gender equality, Alfa Laval recognizes the impact of women in manufacturing and leadership. Ester Codina, President of Alfa Laval North America, exemplifies the progress and ongoing...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2024, along with several significant milestones achieved in recent months....

Enigma Biomedical USA, Inc. (EB USA) today announced that it has selected two (2) four-repeat tau (4R Tau) protein PET imaging biomarkers to advance into Phase 1 (Ph1) studies. Previously, EB USA executed an Exclusive License and Option Agreement...

"AI works 120 million times faster than the human brain," according to Dr. Neilank Jha, neurosurgeon, spine specialist and researcher. But AI ? artificial intelligence ? still needs human oversight. "The ideal approach is human/AI decision-making."...

LUND, SE / ACCESS Newswire / March 21, 2025 / BioInvent International AB ("BioInvent") , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today...

Top Doctors® Group, a leading healthtech company, has announced the 11th Edition of the Top Doctors Awards, recognising the 50 best private healthcare specialists in the UK.     Thousands of medical professionals voted to identify the most...

Almirall, a global pharmaceutical company dedicated to medical dermatology hosts the 16th edition of Skin Academy, a premier conference for healthcare professionals in the field of dermatology. This year's event features a comprehensive program aimed...

Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society of Gynecologic Oncology (SGO). The study evaluates the global first-in-class PD-1/CTLA-4...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by the environmental non-profit CDP for leadership in corporate transparency and...

OrthoMinds, LLC ("OrthoMinds") is providing notice of a recent data security event. OrthoMinds is notifying clients and potentially impacted individuals of the event. This notice provides information about the event, OrthoMinds' response, and steps...

Secretome Therapeutics, a pioneering company in the field of regenerative medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to STM-01, the company's neonatal cardiac progenitor cell (nCPC)...

Pint Pharma and PharmaEssentia announced today that ANVISA (Brazilian Health Regulatory Agency) has approved BESREMi® (ropeginterferon alfa-2b) for the treatment of adult patients with Polycythemia Vera (PV). Polycythemia Vera (PV) is a rare,...

Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G), to reduce proteinuria, making it the first and only treatment approved...

G2S2 Capital Inc. ("G2S2") announces that its wholly owned subsidiary has disposed of 50,000 common shares of Knight Therapeutics Inc. ("Knight"), representing approximately 0.05% of the outstanding common shares of Knight. G2S2's wholly owned...

Today HealthMark Group announced its recognition as a Top Workplace in 2025 by USA Today, highlighting its vision to create an inclusive and growth-oriented work environment for HealthMark's dynamic team of employees who support the company's mission...

Submitted research has nearly doubled to a record-breaking 460 abstracts for the 9th Asian and Oceanian Parkinson's Disease and Movement Disorders Congress (AOPMC). "The depth of novel insights that will be unveiled during the AOPMC showcases the...